Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
Open Access
- 5 August 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 119 (1), 111-118
- https://doi.org/10.1007/s10549-009-0495-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant ChemotherapyJournal of Clinical Oncology, 2009
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast CancerJournal of Clinical Oncology, 2008
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialThe Lancet, 2007
- Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98Journal of Clinical Oncology, 2007
- Aromatase Inhibitors and Bone Loss: Risks in PerspectiveJournal of Clinical Oncology, 2005
- Development and validation of the health assessment questionnaire II: A revised version of the health assessment questionnaireArthritis & Rheumatism, 2004
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerThe New England Journal of Medicine, 2004
- Prevalence of Severe Hypovitaminosis D in Patients With Persistent, Nonspecific Musculoskeletal PainMayo Clinic Proceedings, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002